BeyondSpring Alternatives & Competitors
12 companies similar to BeyondSpring — Based in Duncan, South Carolina, we are a pioneering biotechnology company dedic...
Companies similar to BeyondSpring
Avenzo Therapeutics
Developing the next generation of oncology therapies for patients
OXFORD VACMEDIX UK LIMITED
Developing therapeutic cancer vaccines using ROP technology
NBE-Therapeutics AG
Next generation antibody drug conjugates
Rival Readout
Competing with BeyondSpring? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Arcus Biosciences
Biopharmaceutical company developing differentiated molecules and combination therapies fo...
Apollomics
We are a biopharmaceutical company committed to the discovery and development of mono- and...
Biodexa Pharmaceuticals PLC
Advancing Medicines for a Brighter Future
ROME Therapeutics
Harnessing the power of the repeatome to develop a new class of therapies for cancer and a...
ImmunoMet Therapeutics, Inc.
Targeting Metabolic Reprogramming in Fibrosis and Oncology
Kestrel Therapeutics
We aspire to invent brilliant technologies for difficult cancer targets, beginning with mu...
Glycyx
Restoring immune response in cancer: reversing Opioid-Induced Immunodeficiency to enhance...
Merck & Co., Inc.
Merck develops and produces medicines, vaccines, biologic therapies and animal health prod...
About BeyondSpring
BeyondSpring, based in Duncan, South Carolina, is a pioneering biotechnology company focused on advancing healthcare. Established in 2010, the company operates within the Biopharma industry, specifically targeting the development of innovative cancer therapies to improve clinical outcomes in both the United States and...
Development and commercialization of Plinabulin, Conducting phase 1 to phase 3 clinical trials, Strategic partnerships in drug development, Publications and presentations in scientific journals
Cancer patients, Oncologists, Healthcare providers, Biopharmaceutical partners, Clinical researchers
Cancer Therapies, Immunomodulating Agents, Microtubule-binding Agents, Chemotherapy-induced Neutropenia (CIN), Immuno-oncology, Targeted Protein Degradation, Drug Discovery, Pharmaceutical Development, Clinical Trials, Biopharmaceuticals, Oncology, Phase 3 Study, Breakthrough Therapy, Subsidiary Management
B2B, B2D
Product Sales, Licensing, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around BeyondSpring: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at BeyondSpring on 11 Mar 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.